Oncopeptides AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	205.15	82.26	178.54	173.41	344.52	362.19
Short-Term Investments	-	-	-	0.03	0.35	2.11
Cash & Short-Term Investments	205.15	82.26	178.54	173.44	344.86	364.3
Cash Growth	91.33%	-53.93%	2.94%	-49.71%	-5.33%	-57.27%
Accounts Receivable	41.63	7.77	7.29	2.19	0.67	11.87
Other Receivables	-	8.67	6.24	15.68	16.25	24.01
Receivables	41.63	16.43	13.53	17.87	16.92	35.89
Inventory	9.57	8.24	4.37	2.43	-	-
Prepaid Expenses	-	5.34	6.19	5.43	1.71	7.42
Other Current Assets	-0	5.27	9.96	3.73	0.54	4.76
Total Current Assets	256.35	117.72	217.08	202.9	364.03	412.37
Property, Plant & Equipment	15.55	17.68	27.11	34.63	20.44	24.74
Other Intangible Assets	-	-	-	-	-	1.41
Other Long-Term Assets	-	-	-0	0.85	0.85	0.85
Total Assets	271.89	135.4	244.19	238.38	385.32	439.38
Accounts Payable	13.15	0.7	18.17	15.03	28.22	35.7
Accrued Expenses	-	28.32	15.12	20.38	17.24	36.61
Current Portion of Leases	-	7.72	7.27	5.13	6	10.99
Current Income Taxes Payable	-	1.15	1.73	0.58	0.3	0.05
Current Unearned Revenue	-	0.23	0.07	0.5	-	-
Other Current Liabilities	43.15	6.93	4.66	3.32	33.91	141.94
Total Current Liabilities	56.31	45.06	51.36	44.93	85.67	225.29
Long-Term Debt	130.8	126.68	121.89	106.49	-	-
Long-Term Leases	-	4.98	12.55	19.67	-	3.21
Other Long-Term Liabilities	8	17.56	4.11	10.51	5.36	0.01
Total Liabilities	195.11	194.29	189.91	181.6	91.03	228.51
Common Stock	76.79	30.3	23.91	10.51	10.48	8.37
Additional Paid-In Capital	-	5,814	5,684	5,414	5,403	4,982
Retained Earnings	-	-5,900	-5,651	-5,366	-5,116	-4,778
Comprehensive Income & Other	-	-3.21	-2.84	-2.2	-2.3	-0.92
Shareholders' Equity	76.79	-58.89	54.29	56.78	294.29	210.87
Total Liabilities & Equity	271.89	135.4	244.19	238.38	385.32	439.38
Total Debt	130.8	139.39	141.72	131.29	6	14.19
Net Cash (Debt)	74.35	-57.13	36.82	42.15	338.86	350.11
Net Cash Growth	-	-	-12.65%	-87.56%	-3.21%	-57.98%
Net Cash Per Share	-	-0.25	0.22	0.47	4.12	4.65
Filing Date Shares Outstanding	-	272.71	215.19	94.6	94.31	75.29
Total Common Shares Outstanding	-	272.71	215.19	94.6	94.31	75.29
Working Capital	200.04	72.66	165.73	157.97	278.36	187.08
Book Value Per Share	-	-0.22	0.25	0.60	3.12	2.80
Tangible Book Value	76.79	-58.89	54.29	56.78	294.29	209.46
Tangible Book Value Per Share	-	-0.22	0.25	0.60	3.12	2.78
Machinery	-	16.46	16.46	16.1	15.99	14.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.